期刊
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
卷 104, 期 11, 页码 4261-4266出版社
NATL ACAD SCIENCES
DOI: 10.1073/pnas.0610533104
关键词
biological molecules; Hartree-Fock; quantum mechanics
资金
- NCRR NIH HHS [G12 RR003037, RR 03037] Funding Source: Medline
- NIGMS NIH HHS [S06 GM 606654] Funding Source: Medline
It is possible to use the full power of ab initio quantum mechanics in application to the interaction of drugs and their molecular targets. This idea had barely been realized until recently, because of the well known growth in computational difficulty of the use of quantum mechanics, with the number of atoms in the molecule to be studied. Because the biochemical molecules of medicinal chemistry are so often large, containing thousands or even tens of thousands of atoms, the computational difficulty of the full quantum problem had been prohibitive. Two things have happened, however, that change this perspective: (i) the advances of parallel supercomputers, and (ii) the discovery of a quantum formalism called quantum crystallography and the use of quantum kernels, a method that is well suited for parallel computation. Such advances would allow the quantum mechanical ab initio calculation of the molecular energy of peptides, proteins, DNA, and RNA, obtaining results of high accuracy. In this approach the computational difficulty of representing a molecule increases only modestly with the number of atoms. The calculations are simplified by adopting an acceptable approximation that allows a full biological molecule to be represented by smaller kernels of atoms. These results suggest that problems of medicinal chemistry, such as the rational design of drugs, may be illuminated by quantum mechanical analysis. The general case is illustrated by specific examples, namely, the HF/STO-3G calculations of three aminoglycoside drugs that attach to ribosomal A-site RNA nucleotide targets.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据